Évaluation de la connaissance du traitement et mise en place d’un entretien pharmaceutique ciblé dans le cadre du plan pharmaceutique personnalisé en établissement de santé mentale (notice n° 2042699)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03977cam a2200337 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260405000953.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Helesbeux, Morgane |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Évaluation de la connaissance du traitement et mise en place d’un entretien pharmaceutique ciblé dans le cadre du plan pharmaceutique personnalisé en établissement de santé mentale |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2026.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 28 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | L’entretien pharmaceutique ciblé a notamment pour objectif de favoriser l’adhésion médicamenteuse des patients, en soutien des autres professionnels de santé. L’objectif de ce travail est de présenter la création d’un entretien pharmaceutique ciblé sur la connaissance des traitements suite au bilan de médication. À l’admission, la connaissance du traitement est évaluée grâce à un outil de la Haute Autorité de santé (HAS). L’échelle de Mascard évalue l’adhésion médicamenteuse. Une revue de cas a permis de définir les critères d’éligibilité à l’entretien pharmaceutique ciblé. Un questionnaire de satisfaction, ainsi qu’un appel téléphonique 14 jours après la sortie d’hospitalisation, permettent d’explorer l’influence de cet entretien à distance et en condition de vie réelle. Pendant 14 mois, 19 patients ont bénéficié d’un entretien pharmaceutique ciblé sur un total de 35 patients éligibles. Les entretiens ont été très appréciés par les patients. Quatorze jours après la sortie d’hospitalisation, le score de connaissance a été amélioré pour 9 patients et le score d’adhésion médicamenteuse pour 11 patients en comparaison à leur admission. Ces entretiens s’intègrent au plan pharmaceutique personnalisé permettant le partage d’informations avec le patient, les professionnels de santé de notre établissement et ceux exerçant en ville. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The targeted pharmaceutical interview especially aims to promote patient medication adherence in support of other healthcare professionals. The objective of this work is to present the creation of a targeted pharmaceutical interview on patients’ treatment knowledge following the medication review. Upon admission, treatment knowledge is assessed using a tool from the French National Authority for Health. The Mascard scale assesses medication adherence. A case review was performed to define the eligibility criteria for the targeted pharmaceutical interview. A satisfaction questionnaire and a telephone call 14 days after discharge from hospital are conducted to explore the influence of this interview remotely and in real-life conditions. Over a 14-month period, 19 patients received targeted pharmaceutical interviews out of a total of 35 eligible patients. The interviews were highly appreciated by the patients. Fourteen days after hospital discharge, the knowledge score improved for 9 patients and the medication adherence score for 11 patients compared to their admission. These interviews are part of the personalized pharmaceutical plan which allows to share information with the patient, the healthcare professionals in our establishment and in outpatient settings. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | adhésion médicamenteuse |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | bilan de médication |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | connaissance du traitement |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | entretien pharmaceutique ciblé |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | plan pharmaceutique personnalisé |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | soins pharmaceutiques |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | medication adherence |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | medication review |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | personalized pharmaceutical plan |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | targeted pharmaceutical interview |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | treatment knowledge |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Petit-Miclard, Marie |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kirsner-Besse, |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fournier, Véronique |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Journal de Pharmacie Clinique | 45 | 1 | 2026-03-16 | p. 16-25 | 0291-1981 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://stm.cairn.info/revue-journal-de-pharmacie-clinique-2026-1-page-16?lang=fr&redirect-ssocas=7080">https://stm.cairn.info/revue-journal-de-pharmacie-clinique-2026-1-page-16?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux